NEW YORK (GenomeWeb) – Foundation Medicine said today that it is collaborating with the European Organisation for Research and Treatment of Cancer (EORTC) to provide cancer genomic profiling tests to help determine eligibility of patients for clinical trials.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.